Publications by authors named "Noor Nabila Ajmi"
Front Pharmacol
July 2017
Article Synopsis
- Recent clinical trials indicate that bivalirudin has similar efficacy to heparin for Percutaneous Coronary Intervention (PCI), but provides a better safety profile.
- The analysis included data from 12 randomized controlled trials with over 44,000 subjects, comparing bivalirudin to heparin in patients with angina and acute coronary syndrome.
- While bivalirudin did not significantly reduce all-cause mortality or myocardial infarction compared to heparin, it was associated with a lower risk of major bleeding but a higher risk of stent thrombosis.
